Market Cap | 3.04M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -3.55M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -10.00% |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -62.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -96.00% |
Recommedations | - | Quick Ratio | 0.16 | Shares Outstanding | 207.11M | 52W Low Chg | 317.00% |
Insider Own | 0.07% | ROA | -149.96% | Shares Float | 213.71M | Beta | 0.03 |
Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.00500 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 129 | Target Price | - |
Oper. Margin | - | Earnings Date | - | Volume | 1,750 | Change | 0.00% |
LeanLife Health Inc. provides omega-3 plant-based oils worldwide. The company offers flaxseed products and iron energy drinks. Its omega products can be used in baked goods, processed meats, noodles, beverages, milk products, and chocolates. The company was formerly known as LeenLife Pharma International Inc. and changed its name to LeanLife Health Inc. in January 2018. LeanLife Health Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.